Classes
Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters2015 | First Faculty of Medicine
- Rituximab in hands of a nephrologist - first experience2009 | First Faculty of Medicine
- Long-term follow-up of lymphocyte subpopulations and intracellular cytokines in patients with ANCA-associated vasculitis treated with rituximabPublication without faculty affiliation
- Complement System Deficiencies in Elite Athletes2024 | First Faculty of Medicine
- SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers2022 | First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
- Antibiotics and infections during pregnancy and lactation2021 | First Faculty of Medicine
- Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Science
- Clinical and General Microbiology2020 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...